BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17895469)

  • 1. Pancreatic cancer research matures.
    Nelson NJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1432-4. PubMed ID: 17895469
    [No Abstract]   [Full Text] [Related]  

  • 2. K-ras mutations in circulating DNA from pancreatic and lung cancers: bridging methodology for a common validation of the molecular diagnosis value.
    Magistrelli P; Neri M; Granone P; Cesario A; Paleari L; Russo P
    Pancreas; 2008 Jul; 37(1):101-2. PubMed ID: 18580451
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic adenocarcinoma.
    Ryan DP; Hong TS; Bardeesy N
    N Engl J Med; 2014 Sep; 371(11):1039-49. PubMed ID: 25207767
    [No Abstract]   [Full Text] [Related]  

  • 4. K-ras mutations in the plasma correspond to computed tomographic findings in patients with pancreatic cancer.
    Däbritz J; Preston R; Hänfler J; Oettle H
    Pancreas; 2012 Mar; 41(2):323-5. PubMed ID: 22044911
    [No Abstract]   [Full Text] [Related]  

  • 5. Early detection tools for pancreatic cancer.
    Schmidt C
    J Natl Cancer Inst; 2012 Aug; 104(15):1117-8. PubMed ID: 22851273
    [No Abstract]   [Full Text] [Related]  

  • 6. Autophagy, p53, and pancreatic cancer.
    Iacobuzio-Donahue CA; Herman JM
    N Engl J Med; 2014 Apr; 370(14):1352-3. PubMed ID: 24693896
    [No Abstract]   [Full Text] [Related]  

  • 7. Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine.
    Roukos DH
    Expert Rev Mol Diagn; 2009 Apr; 9(3):217-21. PubMed ID: 19379079
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of predictive markers in oncology: are phase 3 trials always required?
    Markman M
    Oncology; 2011; 81(1):1-2. PubMed ID: 21894048
    [No Abstract]   [Full Text] [Related]  

  • 9. The littlest patient.
    Couzin-Frankel J
    Science; 2014 Oct; 346(6205):24-7. PubMed ID: 25278593
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing methods for the diagnosis of pancreatic cancer.
    Brugge WR
    J Clin Gastroenterol; 2007; 41(10):869-70. PubMed ID: 18090153
    [No Abstract]   [Full Text] [Related]  

  • 11. Targets, trials, and travails in pancreas cancer.
    Izeradjene K; Hingorani SR
    J Natl Compr Canc Netw; 2007 Nov; 5(10):1042-53. PubMed ID: 18053428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation signature in colorectal tumors significantly overlaps with the cetuximab response signature.
    de Reyniès A; Boige V; Milano G; Faivre J; Laurent-Puig P
    J Clin Oncol; 2008 May; 26(13):2228-30; author reply 2230-1. PubMed ID: 18445856
    [No Abstract]   [Full Text] [Related]  

  • 14. Shining the spotlight on shed KRAS in pancreatic cancer.
    Sempere LF; Korc M
    Cancer Biol Ther; 2008 Mar; 7(3):361-3. PubMed ID: 18614859
    [No Abstract]   [Full Text] [Related]  

  • 15. Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
    Garassino MC; Farina G; Rossi A; Martelli O; Torri V
    J Clin Oncol; 2008 May; 26(15):2600; author reply 2601-2. PubMed ID: 18487581
    [No Abstract]   [Full Text] [Related]  

  • 16. Applying synthetic lethality for the selective targeting of cancer.
    McLornan DP; List A; Mufti GJ
    N Engl J Med; 2014 Oct; 371(18):1725-35. PubMed ID: 25354106
    [No Abstract]   [Full Text] [Related]  

  • 17. An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity.
    Ruppen-Cañás I; López-Casas PP; García F; Ximénez-Embún P; Muñoz M; Morelli MP; Real FX; Serna A; Hidalgo M; Ashman K
    Proteomics; 2012 May; 12(9):1319-27. PubMed ID: 22589181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of pancreatic cancer.
    Chaulagain CP; Ng J; Wazer D; Saif MW
    JOP; 2012 Jul; 13(4):349-53. PubMed ID: 22797387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly methylated genes in colorectal neoplasia: implications for screening.
    Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat virus visits the clinic: translating basic discoveries into clinical medicine in the 21st century.
    Boland CR; Goel A
    Gut; 2003 Jan; 52(1):8-9. PubMed ID: 12477748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.